# US 2015/0105429 A1 · Benzyl sulfonamide derivatives as rorc modulators

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105429 A1
- Document ID: US20150105429A1
- Status: Published application
- Kind: A1
- Application number: 14/574,972
- Filed: 2014-12-18
- Published: 2015-04-16
- Earliest claimed: 2011-12-22
- Assignees: Genentech, Inc.
- Applicants: Genentech, Inc.
- Inventors: Benjamin Fauber; Olivier Rene
- Web page: https://patentgrep.com/patent/US20150105429A1

## CPC

- C07D 413/04: directly linked by a ring-member-to-ring-member bond
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 311/13: the carbon skeleton containing six-membered aromatic rings
- C07C 311/16: having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C 311/37: having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C 317/32: with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C 317/48: the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07D 213/42: having hetero atoms attached to the substituent nitrogen atom (nitro radicals C07D213/26)
- C07D 231/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 277/28: Radicals substituted by nitrogen atoms
- C07D 333/20: by nitrogen atoms (nitro, nitroso radicals C07D333/12)
- C07D 333/22: Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
- C07D 333/24: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 409/04: directly linked by a ring-member-to-ring-member bond
- C07D 409/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, A, B, C, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

## Claims

### Claim at position 1

1-19. (canceled)

### Claim 20

A compound of formula I:
or pharmaceutically acceptable salts thereof,
wherein:
A is a group of formula: (a); (b); (c); or (d):
B is a group of formula: (e); (f); (g) or (h):
C is a group of formula: (i); (j); (k); or (m):
m is 0 or 1;
n is from 0 to 3;
p is from 0 to 2;
q is from 0 to 3;
r is from 0 to 3;
s is from 0 to 2;
t is 0 or 1;
u is from 0 to 3;
R1 is: hydrogen; or C1-6alkyl;
R2 is: hydrogen; or C1-6alkyl;
R3 is: C1-6alkyl; C3-6cycloalkyl; C3-6cycloalkyl-C1-6alkyl; heterocyclyl; heterocyclyl-C1-6alkyl; phenyl-C1-6alkyl; or C1-6alkylsulfonyl, wherein the C1-6alkyl, C3-6cycloalkyl C3-6cycloalkyl-C1-6alkyl and phenyl-C1-6alkyl each may be optionally substituted one or more time with halo;
R4 is: hydrogen; or C1-6alkyl;
R5 is: hydrogen; or C1-6alkyl;
R6 is: cyano; —(CH2)v—NRaRb; —(CH2)v—S(O)w—Rc; —(CH2)v—C(O)—NRaRb; —(CH2)v—S(O)w—NRaRb; —(CH2)v—NRd—C(O)—Rc; —(CH2)v—NRd—C(O)—NRaRb; or —(CH2)v—NRd—S(O)w—Rc, wherein:
v is 0 or 1,
w is from 0 to 2;
Ra and Rb each independently is: hydrogen; or C1-6alkyl;
Rc is: C1-6alkyl; C3-6cycloalkyl; or C3-6cycloalkyl-C1-6alkyl; and
Rd is: hydrogen; or C1-6alkyl;
each R7 is independently: C1-6alkyl; halo; C1-6alkoxy; cyano; halo-C1-6alkyl; hydroxy-C1-6alkyl; halo-C1-6alkoxy; or C1-6alkylsulfonyl;
R8 is: C1-6alkyl; C3-6cycloalkyl; or C3-6cycloalkyl-C1-6alkyl;
R9 is: hydrogen; or C1-6alkyl;
R10 is: hydrogen; or C1-6alkyl;
R11 is: hydrogen; hydroxy; cyano; —(CH2)n—NRaRb; —(CH2)n—S(O)v—Rc; —(CH2)n—C(O)—NRaRb; —(CH2)n—S(O)v—NRaRb; —(CH2)n—NRd—C(O)—Rc; —(CH2)v—NRd—C(O)—NRaRb; or —(CH2)n—NRd—S(O)v—Rc.
each R12 is independently: C1-6alkyl; halo; C1-6alkoxy; cyano; halo-C1-6alkyl; halo-C1-6alkoxy; or C1-6alkylsulfonyl;
each R13 is independently: C1-6alkyl; halo; C1-6alkoxy; cyano; halo-C1-6alkyl; halo-C1-6alkoxy; or C1-6alkylsulfonyl;
each R14 is independently: C1-6alkyl; halo; C1-6alkoxy; cyano; halo-C1-6alkyl; halo-C1-6alkoxy; or C1-6alkylsulfonyl;
R15 is: C1-6alkyl; C3-6cycloalkyl; or C3-6cycloalkyl-C1-6alkyl;
R16 is: hydrogen; or C1-6alkyl;
R17 is: hydrogen; or C1-6alkyl;
each R18 is independently: C1-6alkyl; halo; C1-6alkoxy; cyano; halo-C1-6alkyl; halo-C1-6alkoxy; or C1-6alkylsulfonyl; and
R19 is C1-6alkyl;
provided that the compound is not N-isobutyl-N-[5-(3-methanesulfonyl-phenyl)-thiophen-2-ylmethyl]-C-phenyl-methanesulfonamide.

### Claim 21 (depends on 20)

The compound of claim 20, wherein C is a group of formula (i).

### Claim 22 (depends on 20)

The compound of claim 20, wherein A is a group of formula (a).

### Claim 23 (depends on 20)

The compound of claim 20, wherein B is a group of formula (e).

### Claim 24 (depends on 20)

The compound of claim 20, wherein B is a group of formula (f).

### Claim 25 (depends on 20)

The compound of claim 20, wherein m is 0.

### Claim 26 (depends on 20)

The compound of claim 20, wherein m is 1.

### Claim 27 (depends on 20)

The compound of claim 20, wherein R1 and R2 are hydrogen.

### Claim 28 (depends on 20)

The compound of claim 20, wherein R4 and R5 are hydrogen.

### Claim 29 (depends on 20)

The compound of claim 20, wherein R3 is: C1-6alkyl; C3-6cycloalkyl; or C3-6cycloalkyl-C1-6alkyl; each of which may be optionally substituted one or more times with halo.

### Claim 30 (depends on 20)

The compound of claim 20, wherein R3 is C1-6alkyl.

### Claim 31 (depends on 20)

The compound of claim 20, wherein R3 is isobutyl.

### Claim 32 (depends on 20)

The compound of claim 20, wherein A is a group of formula (a1) or (a2):

### Claim 33 (depends on 32)

The compound of claim 32, wherein R6 is: —SO2—Rc; —(CH2)n—C(O)—NRaRb; —(CH2)n—SO2—NRaRb; —(CH2)n—NRd—C(O)—Rc; or —(CH2)n—NRd—SO2—Rc.

### Claim 34 (depends on 20)

The compound of claim 20, wherein the compound is of formula II:

### Claim 35 (depends on 20)

The compound of claim 20, wherein the compound is of formula III:

### Claim 36 (depends on 20)

The compound of claim 20, wherein the compound is of formula IV:

### Claim 37 (depends on 20)

A composition comprising:
(a) a pharmaceutically acceptable carrier; and
(b) a compound of claim 20.

### Claim 38 (depends on 20)

A method for treating arthritis, said method comprising administering to a subject in need thereof an effective amount of a compound of claim 20.
